The synopsis for this grant opportunity is detailed below, following
this paragraph. This synopsis contains all of the updates to this
document that have been posted as of
02/02/2009
. If
updates have been made to the opportunity synopsis, update information
is provided below the synopsis.
If you would like to receive notifications of changes to the grant
opportunity click
send
me change notification emails
.
The only thing you need to provide for this service is your email
address. No other information is requested.
Any inconsistency between the original printed document and the disk
or electronic document shall be resolved by giving precedence to the
printed document.
Document Type:
Grants Notice
Funding Opportunity Number:
W81XWH-09-NFRP-NIA
Opportunity Category:
Discretionary
Posted Date:
Feb 02, 2009
Creation Date:
Feb 02, 2009
Original Closing Date for Applications:
Apr 14, 2009
Current Closing Date for Applications:
Apr 14, 2009
Archive Date:
May 14, 2009
Funding Instrument Type:
Cooperative Agreement
Grant
Category of Funding Activity:
Science and Technology and other Research and Development
Category Explanation:
Expected Number of Awards:
2
Estimated Total Program Funding:
$1,200,000
Award Ceiling:
Award Floor:
CFDA Number(s):
12.420
--
Military Medical Research and Development
Cost Sharing or Matching Requirement:
No
Eligible Applicants
Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"
Additional Information on Eligibility:
Agency Name
Dept. of the Army -- USAMRAA
Description
The NFRP New Investigator Award (NIA) mechanism was first offered in FY99. Since that time, 266 NIA applications have been received and 36 have been recommended for funding.
The intent of the NFRP NIA is to support the career transition and/or continued development of promising independent investigators in the field of neurofibromatosis research. Experience in NF research is allowed, but not required. However, Principal Investigators (PIs) with a limited background in NF research are strongly encouraged to have a collaborator who is experienced in the NF field. To be eligible for this award, PIs must meet the eligibility requirements specified below in Section I.C. NIA proposals must include preliminary data originating from the PI, research team, or collaborator that is relevant to NF and the proposed project.
Areas of Encouragement (Revised for FY09): The FY09 NFRP encourages research proposals that specifically address the critical needs of the NF community in the following areas:
• Complications of NF with high mortality such as neoplasms and cerebrovascular abnormalities;
DOD Neurofibromatosis New Investigator Award 3
• Complications of NF with high morbidity such as skeletal maladies, learning deficits, hormone-associated effects, and pain;
• Refinement and standardization of imaging techniques, molecular and cellular markers, and quality of life metrics for use in future clinical trials; and
• Translational research such as the development or preclinical testing of therapeutic agents for the treatment of NF.
Clinical trials are not allowed under this mechanism. PIs wishing to apply for funding for a clinical trial should utilize the Clinical Trial Award mechanism. See the Program Announcement for the full Funding Opportunity Description.
Link to Full Announcement
If you have difficulty accessing the full announcement
electronically, please contact:
PA HELP: 301-619-7079; cdmrp.pa@amedd.army.mil
eReceipt HELP: 301-682-5507; help@cdmrp.org
CDMRP Helpdesk
Synopsis Modification History
There are currently no modifications for this opportunity.
